Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... .3%, "probable" – 18.1%. Patients with definite FH diagnosis showed higher level of TCh (p<0.001), LDL ..."
 
Vol 1, No 3 (2005) EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim
"... гиполипидемических препаратов или находящихся на гиполипидемической диете в течение 4 недель. Каждый пациент получал ..."
 
Vol 12, No 2 (2016) LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta
"... , and after 1 month while taking rosuvastatin – 4.89±0.81 mmol/l (p<0.001). The change of TC level was -22% (p ..."
 
Vol 8, No 5 (2012) LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS Abstract  similar documents
A. N. Meshkov
"... Дана оценка гиполипидемического действия розувастатина и представлены основные результаты изучения ..."
 
Vol 11, No 4 (2015) TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE Abstract  similar documents
V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova
"... гиполипидемической терапии по данным многопрофильного терапевтического стационара. Материал и методы ..."
 
Vol 14, No 5 (2018) Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation Abstract  similar documents
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov
"... ) у пациентов с сердечно-сосудистыми заболеваниями (ССЗ) при наличии гиперхолестеринемии (ГХС) в ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... динамика в частоте назначения гиполипидемической терапии пациентам высокого и очень высокого сердечно ..."
 
Vol 9, No 2 (2013) MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina
"... группа (n=82; впервые обратившиеся пациенты) и основная подгруппа А (n=167; пациенты, наблюдавшиеся в ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... ; p<0.001) after 6 months was found in patients treated with lipid-lowering therapy in combination ..."
 
Vol 6, No 1 (2010) EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS Abstract  PDF (Eng)  similar documents
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova
"... % (p<0.001), efficiency of heart work by 12% (p<0.05), decrease in frequency of angina attacks by 51 ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... пациентам часто назначают антиагреганты. Обзор клинических и фармакоэпидемиологических исследований ..."
 
Vol 5, No 6 (2009) STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? Abstract  similar documents
I. N. Grigorieva, Y. M. Pozdnyakov
"... эффект пациентов с ГХС достигается при комбинированной терапии статинами и УДХК. Рекомендуют ..."
 
Vol 12, No 3 (2016) EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY Abstract  PDF (Eng)  similar documents
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz
"... Рассматривается влияние гиперлипидемии на заболеваемость и смертность пожилых пациентов. Также ..."
 
Vol 11, No 1 (2015) ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE Abstract  similar documents
M. V. Solodun, S. S. Yakushin
"... эффективность терапии аторвастатином и частоту комбинированной конечной точки у пациентов, перенесших инфаркт ..."
 
Vol 10, No 6 (2014) DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) Abstract  similar documents
A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov
"... атеросклеротического генеза и их осложнений. Цель. Оценить качество диагностики и лечения пациентов с выраженной ГХС ..."
 
Vol 11, No 3 (2015) EVALUATION OF THE REGULARITY OF ANTIHYPERTENSIVE DRUGS USAGE AS A COMPONENT OF TREATMENT ADHERENCE IN OUTPATIENTS OF A SPECIALIZED CARDIOLOGY CENTER Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S.B B. Fitilev
"... врачебных рекомендаций у различных категорий пациентов. Цель. Изучить регулярность приема ..."
 
Vol 13, No 2 (2017) TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1 Abstract  similar documents
M. Yu. Gilyarov, M. O. Zheltoukhova, E. V. Konstantinova, M. D. Muksinova, L. S. Muradova, A. P. Nesterov, A. E. Udovichenko
"... in 2015 compared with 2014 (p<0.0001, risk ratio 0.56, 95% confidence interval 0.420.76). A reduction ..."
 
Vol 15, No 1 (2019) How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice? Abstract  similar documents
M. R. Atabegashvili, E. V. Konstantinova, M. D. Muksinova, A. E. Udovichenko, A. P. Nesterov, M. O. Zheltoukhova, L. S. kyzy Muradova, M. Y. Gilarov
"... <0.001). Angiography data demonstrated more often three-vessel disease (43% vs 29.7%) and less one ..."
 
Vol 7, No 5 (2011) COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... дислипидемией (n=38), не получавшие гиполипидемической терапии, включены в исследование. Пациенты были ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... ) and LDL cholesterol reduced on 25,2% and 33,6% (p<0,001), respectively. Next 6 weeks of therapy ..."
 
Vol 10, No 1 (2014) SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE) Abstract  similar documents
R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. Veldhuisen van, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt
"... . Исследование ставило целью оценить безопасность и эффективность эплеренона у пациентов с высоким риском ..."
 
Vol 12, No 4 (2016) Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... Применение антиаритмических препаратов I класса у пожилых пациентов ограничивают их нежелательные ..."
 
Vol 13, No 5 (2017) IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? Abstract  similar documents
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
"... .14 vs 1.27 in the control group (p<0.001). In the main group, adherence to antihypertensive therapy ..."
 
Vol 11, No 2 (2015) HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... пациентов с ишемической болезнью сердца (ИБС), подтвержден-ной данными коронарной ангиографии (КАГ), за ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... simvastatin TC decreased from 6.4±0.8 to 4.4±0.6 mmol/l (p<0.001) and from 6.0±0.7 to 4.1±0.7 mmol/l (p<0.001 ..."
 
Vol 14, No 4 (2018) Statin Therapy and Cognitive Impairment: Benefit or Harm? Abstract  similar documents
O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova
"... дисфункции у пациентов, терапия статинами не сопровождается риском развития когнитивной дисфункции по данным ..."
 
Vol 5, No 5 (2009) ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS Abstract  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina
"... типа в условиях реальной клинической практики. Материал и методы. 200 пациентов с CД 2-го типа ..."
 
Vol 9, No 4 (2013) EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY Abstract  similar documents
E. V. Goncharova, A. V. Govorin
"... with cardiomyopathy. Flow rate rapid filling re- duced by 27.1% compared with this in control (p<0.001), and flow rate ..."
 
Vol 12, No 3 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 2 Abstract  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... хронических заболеваний, не получавших регулярную медикаментозную терапию. У всех пациентов измерялись ..."
 
Vol 6, No 4 (2010) EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA Abstract  similar documents
P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev
"... application led to significant reduction in levels of TC (from 247.1±27 to 186.5±12 mg/dl; p<0.001), LDC (from ..."
 
Vol 7, No 2 (2011) LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE Abstract  similar documents
A. V. Susekov, N. V. Khokhlova
"... гиполипидемическая эффективность аторвастатина, продемонстрированная в сравнительных исследованиях. Также приводятся ..."
 
Vol 14, No 3 (2018) HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE Abstract  similar documents
O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta
"... ишемическая болезнь сердца и мозговой инсульт. В статье рассматриваются вопросы гиполипидемической терапии ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... density cholesterol (LDC) by 52.4% (p<0.001) was found after 24 weeks in Group 1. Achieving the target LDC ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... .3 mmol/L and 2.3 mmol/L, respectively (p<0.001). Deterioration in the dynamics of alanine ..."
 
Vol 15, No 1 (2019) Prognostic Value of ECG in Patients with Pulmonary Embolism Abstract  similar documents
I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov
"... -complete right bundle branch block (RBBB) (16.3 vs 37.9%; p=0.001), ST segment elevation in lead III (9 ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE Abstract  similar documents
G. I. Nechaeva, E. N. Loginova
"... in the main group in comparison with group of comparison: from 32,5±0,4 to 26,4±0,7 kg/m2 (p<0,01) and from 31 ..."
 
Vol 7, No 5 (2011) EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY Abstract  similar documents
V. M. Provotorov, S. A. Avdeeva
"... increase in hemoglobin (+12.5%; p<0.001) and hematocrit (+5.8%; p<0.001) levels, as well as increase in red ..."
 
Vol 10, No 6 (2014) VALIDATION OF THE MACNEW QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ISHEMIC HEART DISEASE Abstract  PDF (Eng)  similar documents
N. V. Pogosova, A. A. Kursakov, I. H. Boycharov, S. Höfer, N. Oldridge
"... was established in the total sample of ICD patients (0.949; p<0.01). Factor analysis in general substantiated ..."
 
Vol 5, No 3 (2009) CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva
"... Цель. Оценить терапию сердечно-сосудистых заболеваний (ССЗ) у пациентов с сахарным диабетом 2-го ..."
 
Vol 4, No 3 (2008) INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS) Abstract  similar documents
A. V. Kontsevaja, А. М. Kalinina, E. J. Spivak
"... пациентов в течение 12 мес до включения в исследование выявил неадекватную гиполипидемическую терапию и ..."
 
Vol 13, No 1 (2017) LIS-3 REGISTER OF THE ACUTE CORONARY SYNDROME: WHAT HAS CHANGED IN A "PORTRAIT" OF A PATIENT AND SHORT-TERM OUTCOMES OF THE DISEASE COMPARED TO LIS-1 REGISTER Abstract  similar documents
S. Yu. Martsevich, Y. V. Semenova, N. P. Kutishenko, M. L. Ginzburg, A. V. Zagrebelnyy, A. V. Fokina, E. V. Daniels
"... умерших пациентах собиралась из историй  болезней. ЛИС-3 – проспективное исследование; данные  о выживших ..."
 
Vol 13, No 4 (2017) COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina
"... volume (p<0.01),right ventricle anterior-posterior dimension (p<0.001), right atrium volume (p<0.01 ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... , triglyceride (p<0.001) and significant increase in high-density lipoprotein cholesterol (p<0.001) when compared ..."
 
Vol 9, No 5 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... - by 70%, ACE inhibitors - by 60% (p<0.0001). These medications prescription frequency decreased by 15-20 ..."
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... .05). Group 4: the average CHF class decreased by 41.4% (p<0.001), EF increased by 32.8% (p<0.001). Conclusion ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... (Fisher's exact test p<0.05 (bilateral), p<0.01 (one-sided)). The levels of hsCRP, MCP-1 and sVCAM-1 ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... окончательный анализ включены 18273 пациента (58,9% женщин). Гиперхолестеринемия (ГХС) выявлена у 81,3% женщин и ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... открытое исследование включен 161 пациент с СД 2 типа и дислипидемией, из которых 149 пациентов составили ..."
 
Vol 2, No 4 (2006) REPORT ON OPEN MULTICENTRAL RESEARCH PROGRAM “PRIORITY” IN CLINICAL PRACTICE. (PEKTROL – QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA PECTORIS TREATED WITH ISOSORBIDE-5-MONONITRATE IN LONG-ACTING PRESENTATION) Abstract  similar documents
Yu. A. Karpov
"... protocol. The treatment with ISMN reduced the frequency and duration of angina attacks (p<0,001 ..."
 
Vol 14, No 1 (2018) EVALUATION OF LEPTIN SERUM LEVELS IN PATIENTS WITH METABOLIC SYNDROME AND LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY Abstract  PDF (Eng)  similar documents
O. M. Drapkina, R. N. Shepel, T. A. Deeva
"... to the group without MS (17.64±16.87 ng/ml), p<0.001. At that women had significantly higher levels of serum ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... ) as compared to the control group (RR 0.09; 95%CI 0.01-0.9; p=0.04). Conclusion. Treatment with FA, B and B ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... (compensated) of LV remodeling increased by 18% (p<0.001) in group A2, and by 6%, (p=0.03) in group A1. After ..."
 
Vol 15, No 1 (2019) Improving the cognitive functions in the middle-aged patients with essential arterial hypertension after the treatment with amlodipine/valsartan single-pill combination Abstract  similar documents
O. D. Ostroumova, E. V. Borisova, A. I. Kochetkov, T. M. Ostroumova, O. V. Bondarec
"... , diastolic and pulse BP significantly decreased after the treatment with A/V SPC (p<0.001 for systolic ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
"... применения гиполипидемических препаратов в высоких дозах у больных ишемической болезнью сердца (ИБС ..."
 
Vol 5, No 2 (2009) COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
"... systolic and diastolic blood pressure (SBP, DBP) reduced in both groups р<0,0001. There were ..."
 
Vol 9, No 6 (2013) EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE Abstract  similar documents
T. V. Pinchuk, Y. N. Fedulaev, G. A. Khairetdinova, A. A. Kozina, V. N. Ryzhenkov, N. M. Ahmedzhanov
"... early diastolic left ventricular filling velocity) value by 14.1% (p<0.001) and E/A (where A - peak left ..."
 
Vol 13, No 4 (2017) OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT Abstract  similar documents
I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova
"... and hypertriglyceridemia was similar in the compared groups of patients with MS regardless of the presence of gout (p<0.001 ..."
 
Vol 5, No 5 (2009) EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev
"... -diastolic dimension (p<0,001), end-systolic dimension (p<0,001), left atrium (p=0,004), end-diastolic vol ..."
 
Vol 3, No 5 (2007) EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
I. V. Vologdina
"... significantly in the 1st group in comparison with the 2nd group (29,5 % vs 11,5 %, p <0,001). The exercise ..."
 
Vol 12, No 4 (2016) Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov
"... (LVMI) in patients in Group 1 was 134.0±6,5g/m² vs 98.4±3.3 g/m² in Group 2 (p<0.001). LVMI in men ..."
 
Vol 13, No 3 (2017) EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina
"... to valsartan therapy demonstrated a significant increase in 24 h cGMP urinary excretion-on Day 1 (95%, p<0.001 ..."
 
Vol 15, No 1 (2019) The prevalence of sleep breathing disorders in patients with atrial fibrillation undergoing catheter treatment Abstract  similar documents
M. V. Agaltsov, O. M. Drapkina, K. V. Davtyan, G. G. Arutyunyan
"... with OSA were significantly higher than in patients without apnea (p=0.001 and p=0.001, respectively ..."
 
Vol 10, No 1 (2014) ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW Abstract  similar documents
O. N. Semenova, E. A. Naumova, Yu. G. Schwartz
"... Цель. Изучить субъективное мнение пациентов и врачей об их индивидуальном опыте приверженности ..."
 
Vol 10, No 4 (2014) THE EFFICACY OF ANTIHYPERTENSIVE THERAPY IN ELDERLY PATIENTS AND TREATMENT COMPLIANCE ANALYSIS Abstract  similar documents
V. E. Olejnikov, I. V. Eliseeva, Yu. A. Tomashevskaya, N. A. Borisova, S. S. Fadeeva
"... Цель. Изучить эффективность антигипертензивной терапии у пожилых пациентов в условиях ..."
 
Vol 6, No 4 (2010) QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY Abstract  similar documents
A. V. Susekov, V. A. Bulatov, A. V. Vigdorchik
"... was 30.5% and 54.9% respectively, p<0.01, in 6 months and 34.2% and 34.3% respectively in 12 months ..."
 
Vol 6, No 3 (2010) GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY Abstract  similar documents
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev
"... ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА ПЕРЕД ОПЕРАЦИЯМИ И ВЕДЕНИЮ ПАЦИЕНТОВ ПРИ НЕКАРДИАЛЬНЫХ ОПЕРАЦИЯХ ..."
 
Vol 9, No 4 (2013) EFFECT OF MAGNESIUM OROTATE ON CONNECTIVE TISSUE MATRIX AND CARDIAC INOTROPIC FUNCTION IN PATIENTS WITH MITRAL VALVE PROLAPSE. CLINICAL AND MORPHOLOGICAL STUDY Abstract  similar documents
A. G. Avtandilov, K. M. Dzeranova, T. G. Borovaya, L. V. Didenko
"... .9 ± 0.4%, respectively; p<0.001). According to the echocardiography increase in the end-diastolic (from ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... (p<0.001), they were more often diagnosed with left ventricular aneurysm (p=0.001), chronic kidney ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... to the first and to control groups. In the second group LF increased from 223.8±56.2 to 734±90.9 мs2 (p<0.001 ..."
 
Vol 7, No 3 (2011) PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
V. A. Sulimov, A. S. Lishuta
"... Рассматривают основные принципы ведения пациентов с фибрилляцией предсердий (ФП) с учетом ..."
 
Vol 4, No 4 (2008) LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Abstract  similar documents
A. S. Kerimkulova, A. M. Noruzbaeva, O. S. Lunegova, B. Z. Imanov, M. A. Pavlenko, A. E. Mirrahimov, I. JU. Gottfried, E. M. Mirrahimov
"... 84 пациента с ишемической болезнью сердца (ИБС) и дислипидемией в возрасте 42-65 (54,3±6,5) лет ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... кровообращения, а также мнения о пользе ТКИМ для реклассификации пациентов с признаками субклинического ..."
 
Vol 6, No 5 (2010) EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY Abstract  similar documents
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva
"... .1 min-1) than in group 2 (74,5±8,2 and 73,9±7,0 min-1, respectively, p<0,001 for both periods ..."
 
Vol 6, No 5 (2010) INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  PDF (Eng)  similar documents
E. N. Golovenko, D. A. Napalkov, V. A. Sulimov
"... (FC) III-IV than in those with CHF of FC I-II (p<0.001). Negative correlation was revealed between TrI ..."
 
Vol 2, No 4 (2006) POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN Abstract  similar documents
I. V. Logacheva, E. N. Shustova, E. V. Kulinich
"... гиполипидемическому и плейотропному эффекту потенцировал позитивное влияния фозиноприла на уменьшение гипертрофии ..."
 
Vol 15, No 3 (2019) Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... valve in patients of groups 1 and 2 was lower than in the control by 15% and 17%, respectively (p<0.001 ..."
 
Vol 12, No 6 (2016) EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... myocardial mass (from 170 [225.5;213.5] to 159 [146;167] g; p<0.001), and size of the left atrium (LA; from ..."
 
Vol 11, No 5 (2015) Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease Abstract  similar documents
O. A. Rubanenko
"... и методы. Обследовано 105 пациентов с ИБС, которые распределены на 2 группы: 1 группа получала ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... of patients with b-blockers (p<0.001), RAAS inhibitors (p<0.01), antiplatelet agents (p<0.05) and statins (p<0.001 ..."
 
Vol 5, No 6 (2009) EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
"... Цель. Оценить эффективность и безопасность рамиприла (Хартил, Egis) в лечении пациентов различных ..."
 
Vol 10, No 3 (2014) EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... <0.001) were revealed. The right ventricle increased in size with the impairment of its diastolic ..."
 
Vol 9, No 3 (2013) INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina
"... with muscle symptoms received statins significantly longer (48.8 vs 11.9 months, р<0.0001) and in higher doses ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... наиболее уязвимой группы пациентов с фибрилляцией предсердий (ФП): при высоком  риске развития ..."
 
Vol 14, No 5 (2018) Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting Abstract  similar documents
A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash
"... prognosis increased 3.6-fold the risk of long-term MACEs (OR 3.617; 95%CI 1.557-8.403, p=0.001). Conclusion ..."
 
Vol 12, No 1 (2016) Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease Abstract  PDF (Eng)  similar documents
E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova
"... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..."
 
Vol 6, No 1 (2010) ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY Abstract  similar documents
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik
"... . SBP decreased by 37,5 mm Hg (р<0,01) in smoking patients and by 37,6 mm Hg (р<0,01) in non-smoking ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... Цель. Изучить особенности состояния гемостаза и активности ферментов тромбоцитов у пациентов с ..."
 
Vol 15, No 3 (2019) Effect of the Single-Pill Amlodipine/Valsartan Combination on Hypertrophy and Myocardial Deformation Characteristics in Middle-Aged Patients with Essential Arterial Hypertension Abstract  similar documents
A. I. Kochetkov, E. V. Borisova, O. D. Ostroumova, M. V. Lopukhina, G. V. Piksina
"... at baseline after the treatment with A/V SPC significantly decreased (p<0.001 for all) interventricular septum ..."
 
Vol 4, No 3 (2008) DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY Abstract  similar documents
E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin
"... <0,01). Conclusion. Liptonorm therapy improves autonomic balance in patients with IHD and paroxysmal ..."
 
Vol 11, No 6 (2015) The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev
"... .06); the presence of 2, 3, 4 and 5 comorbidities – respectively, by 4, 5, 6.4 and 13 times (p<0.001). The risk ..."
 
Vol 6, No 4 (2010) PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov
"... ) decreased significantly in comparison with the baseline level (p<0.0001). Dose doubling of beta-blockers ..."
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"... conventionally managed. Kaplan-Meier curves revealed that risk of CHF decompensation (р=0.001), mortality (р=0 ..."
 
Vol 8, No 1 (2012) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... клинических исследований. К хорошо известным гиполипидемическим эффектам ω-3 ПНЖК получены результаты их ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... .8±8.4 and -30.4±12.8/18.7±8 mm Hg for groups 1 and 2, respectively , p<0.001 for the both groups ..."
 
Vol 15, No 2 (2019) Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... - 0.9 [0.8;1.31 ], in the 2nd group - 0.8 [0.78; 1.2] with a control value of 1.6 [1.2;1.94] (p<0.001 ..."
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
"... Цель. Оценить антигипертензивный и гиполипидемический эффект группы лекарственных средств ..."
 
Vol 4, No 1 (2008) EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE Abstract  similar documents
S. A. Smakotina, O. A. Trubnikova, O. L. Barbarash
"... and night-time pulse BP. Left ventricular mass index reduced significantly (p<0,0001). After 6 months ..."
 
Vol 8, No 4 (2012) INHALED NITRIC OXIDE: CLINICAL EFFECTS AND INFLUENCE ON THE PROFILE OF INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION Abstract  similar documents
T. V. Martynyuk, S. N. Nakonechnikov, V. P. Masenko, I. E. Chazova
"... with ΔSPAP , and ΔIL-6 correlated with ΔFC and Δ6MWT distance (30.5 [21.0; 53.0] m; p<0.001). This allows ..."
 
Vol 14, No 2 (2018) EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, Е. E. Shkolnikova, O. I. Lukina
"... with a decrease in central systolic blood pressure (from 116Ѓ}19 to 106Ѓ}10 mm Hg; p=0.001) and central pulse ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... атеросклерозом. Освещаются основные этапы в развитии гиполипидемической терапии, ее современные цели и спо-собы ..."
 
1 - 100 of 1403 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)